Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
4
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
deals
gene therapy
merck
pfizer
abeona therapeutics
alnylam pharmaceuticals
alzheimer's
biogen
cancer
clinical trials
What
bio
roundup
patients
drug
terms
acquisitions
advantages
albert
alzheimer’s
bar
becker
biggest
billions
bourla
brings
ceo
company
congress
crispr
democrats
divided
dollars
eaton
elections
expect
fallout
future
gamble
gene
healthcare
impact
imports
life
losses
maker
maps
market
measured
medco’s
michael
Language
unknown
unset
Current search:
medicare
×
novartis
×
amgen
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel